Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)

Pharmaceutical companies have increasingly utilized genomic data for the selection of drug targets and the development of precision medicine approaches. Most major pharmaceutical companies routinely collect DNA from clinical trial participants and conduct pharmacogenomic (PGx) studies. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bienfait, Karina, Chhibber, Aparna, Marshall, Jean-Claude, Armstrong, Martin, Cox, Charles, Shaw, Peter M., Paulding, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177658/
https://www.ncbi.nlm.nih.gov/pubmed/34081195
http://dx.doi.org/10.1007/s00439-021-02282-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177658/
https://www.ncbi.nlm.nih.gov/pubmed/34081195
http://dx.doi.org/10.1007/s00439-021-02282-3

Ejemplares similares